|
Market Closed -
London S.E.
09:05:29 11/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 11,708.00 GBX | -0.43% |
|
-2.48% | -15.10% |
| 12/09 | AstraZeneca Says Late-Stage Etcamah Breast-Cancer Trial Misses Main Goal | MT |
| 12/09 | AstraZeneca's breast cancer pill fails in late-stage trial | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASTRAZENECA PLC | Other Pharmaceuticals | -0.43% | -2.48% | -15.10% | -2.07% | +43.25% | 25TCr |  |  | |
- Stock Market
- Stocks
- AZN Stock
- Charts AstraZeneca PLC
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
